FILIPPI, SANDRA
 Distribuzione geografica
Continente #
NA - Nord America 11.682
EU - Europa 5.451
AS - Asia 3.911
SA - Sud America 492
Continente sconosciuto - Info sul continente non disponibili 212
AF - Africa 115
OC - Oceania 94
Totale 21.957
Nazione #
US - Stati Uniti d'America 11.499
RU - Federazione Russa 1.893
IT - Italia 1.290
SG - Singapore 1.116
CN - Cina 903
HK - Hong Kong 604
SE - Svezia 457
IE - Irlanda 436
BR - Brasile 393
VN - Vietnam 354
KR - Corea 323
PL - Polonia 262
DE - Germania 245
IN - India 193
UA - Ucraina 171
GB - Regno Unito 169
FI - Finlandia 159
FR - Francia 147
CA - Canada 113
AU - Australia 91
CH - Svizzera 88
TR - Turchia 78
JP - Giappone 61
BD - Bangladesh 51
AR - Argentina 40
JO - Giordania 40
ID - Indonesia 35
NL - Olanda 31
MX - Messico 30
IR - Iran 28
ZA - Sudafrica 26
IQ - Iraq 24
BE - Belgio 22
ES - Italia 22
AT - Austria 20
CI - Costa d'Avorio 19
CO - Colombia 19
NG - Nigeria 16
EC - Ecuador 15
PK - Pakistan 15
SA - Arabia Saudita 13
MA - Marocco 12
SC - Seychelles 11
PH - Filippine 10
VE - Venezuela 10
JM - Giamaica 9
RO - Romania 9
DZ - Algeria 7
LT - Lituania 7
UZ - Uzbekistan 7
AZ - Azerbaigian 6
EG - Egitto 6
IL - Israele 6
MY - Malesia 6
TN - Tunisia 6
CL - Cile 5
CR - Costa Rica 5
KZ - Kazakistan 5
TH - Thailandia 5
BH - Bahrain 4
BY - Bielorussia 4
HN - Honduras 4
NP - Nepal 4
PE - Perù 4
TW - Taiwan 4
BG - Bulgaria 3
GT - Guatemala 3
NZ - Nuova Zelanda 3
PT - Portogallo 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
AE - Emirati Arabi Uniti 2
BA - Bosnia-Erzegovina 2
BB - Barbados 2
BO - Bolivia 2
CZ - Repubblica Ceca 2
ET - Etiopia 2
KG - Kirghizistan 2
MO - Macao, regione amministrativa speciale della Cina 2
NI - Nicaragua 2
OM - Oman 2
PA - Panama 2
SN - Senegal 2
SY - Repubblica araba siriana 2
AL - Albania 1
AM - Armenia 1
BJ - Benin 1
BM - Bermuda 1
CG - Congo 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
GA - Gabon 1
GD - Grenada 1
GP - Guadalupe 1
GR - Grecia 1
GY - Guiana 1
HR - Croazia 1
KE - Kenya 1
Totale 21.727
Città #
Santa Clara 1.543
Ashburn 1.366
Fairfield 882
Singapore 801
Chandler 586
Hong Kong 500
San Jose 442
Dublin 435
Woodbridge 398
Seattle 370
Cambridge 333
Houston 332
Jacksonville 303
Wilmington 299
Seoul 286
Warsaw 261
Milan 218
Beijing 192
Altamura 168
Los Angeles 166
Lawrence 165
Ann Arbor 158
Buffalo 152
Hefei 150
Council Bluffs 145
Florence 124
Princeton 121
The Dalles 121
Rome 116
Boston 100
Lauterbourg 100
Ho Chi Minh City 98
Dallas 95
New York 93
Hanoi 83
Bern 80
Melbourne 75
Boardman 74
Moscow 69
Mumbai 69
San Diego 69
Munich 67
Medford 53
Atlanta 52
Tokyo 52
Shanghai 51
Phoenix 49
Chicago 44
Izmir 41
Helsinki 34
Kent 33
Orem 33
São Paulo 32
Denver 31
Naples 30
Toronto 30
Paris 27
Turin 26
Falls Church 25
Guwahati 25
Brooklyn 23
Columbus 23
London 23
Miano 23
Patna 23
Turku 23
Detroit 22
San Francisco 22
Brussels 21
Redondo Beach 21
Haiphong 20
Hillsboro 20
Redwood City 20
Abidjan 19
Da Nang 19
Figino 19
Jakarta 19
Norwalk 19
Bologna 18
Chennai 17
Guangzhou 17
Venice 17
Vienna 17
Philadelphia 16
Bari 15
Colorno 15
Sydney 15
Verona 15
Abuja 14
Auburn Hills 14
Frankfurt am Main 14
Genoa 14
Montreal 14
Belo Horizonte 13
Dearborn 13
Clifton 12
Frankfurt Am Main 12
Manchester 12
Ottawa 12
Rochester 12
Totale 13.570
Nome #
Consequences of Anabolic-Androgenic Steroid Abuse in Males; Sexual and Reproductive Perspective. 630
Glymphatic system alteration in an animal model of metabolic syndrome 487
Endothelium-dependent relaxant properties are involved in the mechanisms of action of yohimbine 397
Sex Steroid Receptors in Male Human Bladder: Expression and Biological Function. 328
Oxytocin receptor is expressed in the penis and mediates an estrogen-dependent smooth muscle contractility 307
Anti-fibrotic effects of chronic treatment with the selective FXR agonist obeticholic acid in the bleomycin-induced rat model of pulmonary fibrosis. 301
Androgens regulate Phosphodiesterase type 5 expression and functional activity in corpora cavernosa 297
Nonalcoholic steatohepatitis as a novel player in metabolic syndrome-induced erectile dysfunction: an experimental study in the rabbit. 297
Differential Effects of Testosterone and Estradiol on Clitoral Function: An Experimental Study in Rats 290
INT-767 prevents NASH and promotes visceral fat brown adipogenesis and mitochondrial function 272
Acute vardenafil administration improves bladder oxygenation in spontaneously hypertensive rats. 253
Anti-inflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells. 244
Anti-inflammatory effects of androgens in the human vagina 237
Characterization and functional role of androgen-dependent PDE5 activity in the bladder. 235
Insight on the intracrinology of menopause: androgen production within the human vagina 234
Testosterone improves muscle fiber asset and exercise performance in a metabolic syndrome model. 231
Identification, characterization and biological activity of oxytocin receptor in the developing human penis. 226
Cardiopulmonary protective effects of the selective FXR agonist obeticholic acid in the rat model of monocrotaline-induced pulmonary hypertension. 226
FXR activation normalizes insulin sensitivity in visceral preadipocytes of a rabbit model of MetS. 218
Testosterone positively regulates vagina NO-induced relaxation: an experimental study in rats 218
Atorvastatin but not elocalcitol increases sildenafil responsiveness in spontaneously hypertensive rats by regulating the RhoA/ROCK pathway. 216
Tadalafil reduces visceral adipose tissue accumulation by promoting preadipocytes differentiation towards a metabolically healthy phenotype: Studies in rabbits. 215
Physical activity counteracts metabolic syndrome-induced hypogonadotropic hypogonadism and erectile dysfunction in the rabbit. 214
Testosterone does not affect lower urinary tract symptoms while improving markers of prostatitis in men with benign prostatic hyperplasia: a randomized clinical trial 212
Identification, localization and functional in vitro and in vivo activity of oxytocin receptor in the rat penis. 211
Opposite effects of tamoxifen on metabolic syndrome-induced bladder and prostate alterations: A role for GPR30/GPER? 209
BXL-628, a vitamin D receptor agonist effective in benign prostatic hyperplasia treatment, prevents RhoA activation and inhibits RhoA/Rho kinase signaling in rat and human bladder. 205
Testosterone regulates RhoA/Rho-kinase signaling in two distinct animal models of chemical diabetes. 202
Antiangiogenic Properties Of Selected Ruthenium(III) Complexes That Are Nitric Oxide Scavengers 201
Atorvastatin ameliorates sildenafil-induced penile erections in experimental diabetes by inhibiting diabetes-induced RhoA/Rho-kinase signaling hyperactivation. 199
Oxytocin mediates the estrogen-dependent contractile activity of endothelin-1 in human and rabbit epididymis. 198
Functional adenosine receptors in human corpora cavernosa 196
Effects of NCX 4050, a new NO donor, in rabbit and human corpus cavernosum. 196
Therapeutic effects of the selective farnesoid X receptor agonist obeticholic acid in a monocrotaline-induced pulmonary hypertension rat model. 194
Estrogen mediates metabolic syndrome-induced erectile dysfunction: a study in the rabbit. 193
Mechanism of action of phosphodiesterase type 5 inhibition in metabolic syndrome-associated prostate alterations: An experimental study in the rabbit. 192
Intracellular pathways triggered by the selective Flt-1-agonist Placental Growth Factor in vascular smooth muscle cells exposed to hypoxia 191
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells. 190
Characterization of phosphodiesterase type 5 expression and functional activity in the human male lower urinary tract. 190
Blockade of adenosine receptors unmasks a stimulatory effect of ATP on cardiac contractility 190
Phosphodiesterase type 5 expression in human and rat lower urinary tract tissues and the effect of tadalafil on prostate gland oxygenation in spontaneously hypertensive rats. 187
Antiinflammatory effect of androgen receptor activation in human benign prostatic hyperplasia cells (Erratum) 187
Age-dependent modifications of the role of prostanoids in cardiac preparations from normotensive and hypertensive rats 186
Therapeutic effects of obeticholic acid (OCA) treatment in a bleomycin-induced pulmonary fibrosis rat model 186
Human prostatic urethra expresses Vitamin D receptor and responds to Vitamin D receptor ligation. 185
METABOLIC SYNDROME-ASSOCIATED SPERM ALTERATIONS IN AN EXPERIMENTAL RABBIT MODEL: RELATION WITH METABOLIC PROFILE, TESTIS AND EPIDIDYMIS GENE EXPRESSION AND EFFECT OF TAMOXIFEN TREATMENT 184
Erectile dysfunction: molecular biology, pathophysiology and pharmacological treatment. 182
Effect of sildenafil administration on penile hypoxia induced by cavernous neurotomy in the rat. 181
Testosterone protects from metabolic syndrome-associated prostate inflammation: An experimental study in rabbit 181
Vardenafil can improve continence recovery after bilateral nerve sparing prostatectomy: results of a randomized, double blind, placebo-controlled pilot study. 180
Testosterone treatment improves metabolic syndrome-induced adipose tissue derangements. 180
Farnesoid X Receptor Activation Improves Erectile Function in Animal Models of Metabolic Syndrome and Diabetes. 180
Vasorelaxant effects induced by the antiangiogenic drug linomide in aortic and saphenous vein preparations of the rabbit 179
Testosterone treatment is associated with reduced adipose tissue dysfunction and nonalcoholic fatty liver disease in obese hypogonadal men 178
Testosterone and farnesoid X receptor agonist INT-747 counteract high fat diet-induced bladder alterations in a rabbit model of metabolic syndrome. 177
Cavernous Neurotomy in the Rat is Associated with the Onset of an Overt Condition of Hypogonadism. 176
Expression and functional activity of phosphodiesterase type 5 in human and rabbit vas deferens. 174
Cardiovascular Risks of Androgen Deprivation Therapy for Prostate Cancer 173
The regulatory effect of sex steroids on the RhoA/ROCK pathway in the rat distal vagina 172
Sexual function in men undergoing androgen deprivation therapy. 172
Adenosine relaxes vagina smooth muscle through the cyclic guanosine monophosphate– and cyclic guanosine monophosphate–dependent pathways 171
Peripheral regulatory mechanisms in erection 171
Metabolic syndrome induces inflammation and impairs gonadotropin-releasing hormone neurons in the preoptic area of the hypothalamus in rabbits. 171
The vitamin D receptor agonist elocalcitol upregulates L-type calcium channel activity in human and rat bladder 170
Endothelium-dependency of yohimbine-induced corpus cavernosum relaxation 170
Upregulation of L-type Ca2+ channel activity by the vdr agonist elocalcitol in human and rat bladder 169
Alpha-1D adrenoreceptors cause endothelium-dependent vasodilatation in the rat mesenteric bed 168
ENDOGENOUS VEGF-A IS RESPONSIBLE FOR THE MITOGENIC EFFECT OF MONOCYTE CHEMOTACTIC PROTEIN-1 ON VASCULAR SMOOTH MUSCLE CELLS 168
Tadalafil effect on metabolic syndrome-associated bladder alterations: an experimental study in a rabbit model. 167
Effect of chronic tadalafil administration on penile hypoxia induced by cavernous neurotomy in the rat. 166
PDE5 inhibitors blunt inflammation in human BPH: a potential mechanism of action for PDE5 inhibitors in LUTS. 166
Metformin in vitro and in vivo increases adenosine signaling in rabbit corpora cavernosa. 166
ERECTILE DYSFUNCTION: FROM BIOCHEMICAL PHARMACOLOGY TO ADVANCES IN MEDICAL THERAPY. 165
Testosterone restores diabetes-induced erectile dysfunction and sildenafil responsiveness in two distinct animal models of chemical diabetes. 165
Inositol phosphate metabolism and Nitric oxide-synthase activity in endothelial cells are involved in the vasorelaxant activity of nebivolol 163
Testosterone/Estradiol Ratio Regulates NO-Induced Bladder Relaxation and Responsiveness to PDE5 Inhibitors. 161
ROLE OF OXYTOCIN IN THE EJACULATORY PROCESS. 159
Identification, characterization, and biological activity of endothelin receptors in human ovary. 158
Sex steroids and leptin regulate the "first Kiss" (KiSS 1/G-protein-coupled receptor 54 system) in human gonadotropin-releasing-hormone-secreting neuroblasts. 158
Which patients with sexual dysfunction are suitable for testosterone replacement therapy? 157
Trophic effects induced by alpha-1d adrenoceptors on endothelial cells are potentiated by hypoxia 157
Distal vagina smooth muscle contractility mechanisms: effects of in vivo sex steroids treatment in an animal experimental model of ovariectomy 156
Dihydrotestosterone and leptin regulate gonadotropin-releasing hormone (GnRH) expression and secretion in human GnRH-secreting neuroblasts. 155
The galectin-3 inhibitor selvigaltin reduces liver inflammation and fibrosis in a high fat diet rabbit model of metabolic-associated steatohepatitis 152
From bedside to bench: calcium gluconate is an effective treatment in hydrofluoric acid skin burns and reverses fluoride induced vasoconstriction in vitro 151
Positive inotropic effects of CGRP and isoprenaline: analogies and differences 148
Studies on the mechanisms involved in the ATP-induced relaxation in human and rabbit corpus cavernosum. 145
Spermatogenic and sperm quality differences in an experimental model of Metabolic Syndrome and Hypogonadal Hypogonadism. 145
Cardiovascular effects of capsaicin-sensitive neurons 144
Characterization of metabolic syndrome-related morpho-functional changes in the lung and the role of testosterone treatment in an animal model. 142
Estrogens, but not androgens, regulate expression and functional activity of oxytocin receptor in rabbit epididymis. 141
Modulation by adrenergic transmitters of the efferent function of capsaicin-sensitive nerves in cardiac tissue 137
Modulation of adrenergic responses by prostanoids in the isolated mesenteric vascular bed of the rat 136
Treatment potential of LPCN 1144 on liver health and metabolic regulation in a non-genomic, high fat diet induced NASH rabbit model. 135
Testosterone regulates PDE5 expression andl in vivo responsiveness to tadalafil in rat corpus cavernosum. 134
Cellular mechanisms involved in the vasorelaxant effect induced by alpha adrenoreceptor stimulation in isolated resistance vessels 133
Identification, localization and functional activity of oxytocin receptors in epididymis 133
Erectile dysfunction and central obesity: an Italian perspective. 132
Testosterone partially ameliorates metabolic profile and erectile responsiveness to PDE5 inhibitors in an animal model of male metabolic syndrome. 132
Neuroprotective Effects of Testosterone in the Hypothalamus of an Animal Model of Metabolic Syndrome 132
Totale 19.691
Categoria #
all - tutte 64.314
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 64.314


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022860 0 0 132 38 29 26 37 83 52 16 222 225
2022/20232.257 190 491 85 169 184 380 260 115 200 20 57 106
2023/2024694 26 90 129 30 50 80 28 134 32 28 38 29
2024/20255.094 185 496 322 806 1.486 472 121 368 259 174 229 176
2025/20266.526 680 824 426 364 814 230 798 314 390 375 181 1.130
2026/20271.976 906 454 616 0 0 0 0 0 0 0 0 0
Totale 21.957